These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35214181)

  • 21. Fractionated Er:YAG laser versus fully ablative Er:YAG laser for scar revision: Results of a split scar, double blinded, prospective trial.
    Tidwell WJ; Owen CE; Kulp-Shorten C; Maity A; McCall M; Brown TS
    Lasers Surg Med; 2016 Nov; 48(9):837-843. PubMed ID: 27426441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fractional laser as a tool to enhance the skin permeation of 5-aminolevulinic acid with minimal skin disruption: a comparison with conventional erbium:YAG laser.
    Lee WR; Shen SC; Pai MH; Yang HH; Yuan CY; Fang JY
    J Control Release; 2010 Jul; 145(2):124-33. PubMed ID: 20359510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erbium:YAG laser-mediated oligonucleotide and DNA delivery via the skin: an animal study.
    Lee WR; Shen SC; Liu CR; Fang CL; Hu CH; Fang JY
    J Control Release; 2006 Oct; 115(3):344-53. PubMed ID: 17005286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of fractional neodymium-doped yttrium aluminum garnet (Nd:YAG) 1064-nm picosecond laser and fractional 1550-nm erbium fiber laser in facial acne scar treatment.
    Chayavichitsilp P; Limtong P; Triyangkulsri K; Pratumchart N
    Lasers Med Sci; 2020 Apr; 35(3):695-700. PubMed ID: 31646393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erbium:YAG laser enhances transdermal peptide delivery and skin vaccination.
    Lee WR; Pan TL; Wang PW; Zhuo RZ; Huang CM; Fang JY
    J Control Release; 2008 Jun; 128(3):200-8. PubMed ID: 18471920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of biophysical properties of skin measured by using non-invasive techniques in the KM mice following 595 nm pulsed dye, 1064 nm Q-Switched Nd:YAG and 1320 nm Nd:YAG laser non-ablative rejuvenation.
    Dang Y; Ren Q; Li W; Yang Q; Zhang J
    Skin Res Technol; 2006 May; 12(2):119-25. PubMed ID: 16626386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined fractional ablative and nonablative laser resurfacing treatment: a split-face comparative study.
    Cohen JL; Ross EV
    J Drugs Dermatol; 2013 Feb; 12(2):175-8. PubMed ID: 23377390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A single-blinded, randomized, controlled trial comparing efficacy between low-fluence alexandrite 755-nm picosecond laser and low-fluence neodymium-doped yttrium aluminum garnet (Nd:YAG) 1064-nm picosecond laser for the treatment of ultraviolet B-induced hyperpigmentation.
    Vachiramon V; Namasondhi A; Anuntrangsee T; Jurairattanaporn N
    J Cosmet Dermatol; 2022 Mar; 21(3):1036-1044. PubMed ID: 34773725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
    Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
    J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ablative fractionated erbium:YAG laser for the treatment of ice pick alar scars due to neodymium:YAG laser burns.
    Cohen JL; Babcock MJ
    J Drugs Dermatol; 2009 Jan; 8(1):65-7. PubMed ID: 19180898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erbium:YAG laser resurfacing increases skin permeability and the risk of excessive absorption of antibiotics and sunscreens: the influence of skin recovery on drug absorption.
    Lee WR; Shen SC; Al-Suwayeh SA; Li YC; Fang JY
    Toxicol Lett; 2012 Jun; 211(2):150-8. PubMed ID: 22483991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of CO2, Nd:YAG and Er:YAG lasers with and without surface coolant on tooth root surfaces. An in vitro study.
    Israel M; Cobb CM; Rossmann JA; Spencer P
    J Clin Periodontol; 1997 Sep; 24(9 Pt 1):595-602. PubMed ID: 9378829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term results of the combined application of neodymium-doped yttrium aluminum garnet (Nd:YAG) laser and erbium-doped yttrium aluminum garnet (Er:YAG) laser in the treatment of periodontal disease: a randomized controlled trial.
    Laky M; Müller M; Laky B; Arslan M; Wehner C; Husejnagic S; Lettner S; Moritz A; Rausch-Fan X
    Clin Oral Investig; 2021 Nov; 25(11):6119-6126. PubMed ID: 33813638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noninvasive delivery of siRNA and plasmid DNA into skin by fractional ablation: erbium:YAG laser versus CO₂ laser.
    Lee WR; Shen SC; Chen WY; Aljuffali IA; Suen SY; Fang JY
    Eur J Pharm Biopharm; 2014 Apr; 86(3):315-23. PubMed ID: 23962771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of the 300 microsecond 1064 nm Nd:YAG laser in the treatment of keloids.
    Rossi A; Lu R; Frey MK; Kubota T; Smith LA; Perez M
    J Drugs Dermatol; 2013 Nov; 12(11):1256-62. PubMed ID: 24196333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of responses of tattoos to picosecond and nanosecond Q-switched neodymium: YAG lasers.
    Ross V; Naseef G; Lin G; Kelly M; Michaud N; Flotte TJ; Raythen J; Anderson RR
    Arch Dermatol; 1998 Feb; 134(2):167-71. PubMed ID: 9487208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative effectiveness of nonpurpuragenic 595-nm pulsed dye laser and microsecond 1064-nm neodymium:yttrium-aluminum-garnet laser for treatment of diffuse facial erythema: A double-blind randomized controlled trial.
    Alam M; Voravutinon N; Warycha M; Whiting D; Nodzenski M; Yoo S; West DP; Veledar E; Poon E
    J Am Acad Dermatol; 2013 Sep; 69(3):438-43. PubMed ID: 23688651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laser-assisted topical drug delivery by using a low-fluence fractional laser: imiquimod and macromolecules.
    Lee WR; Shen SC; Al-Suwayeh SA; Yang HH; Yuan CY; Fang JY
    J Control Release; 2011 Aug; 153(3):240-8. PubMed ID: 21435360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Will Repeated Ablative Er:YAG Laser Treatment Sessions Cause Facial Skin Sensitivity? Results of a 12-Month, Prospective, Randomized Split-Face Study.
    Wang X; Yuan C; Wo Y; Qian L; Liu K; Zhang Z; Zhang Y; Xu H; Chen X; Biskup E
    Rejuvenation Res; 2020 Apr; 23(2):122-129. PubMed ID: 31032742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Ablative Fractional CO2 Laser and Er:YAG Laser to Treat Hypertrophic Scars in a Red Duroc Pig Model.
    Rodriguez-Menocal L; Davis SS; Becerra S; Salgado M; Gill J; Valdes J; Candanedo A; Natesan S; Solis M; Guzman W; Higa A; Schulman CI; Christy RJ; Waibel J; Badiavas EV
    J Burn Care Res; 2018 Oct; 39(6):954-962. PubMed ID: 29718376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.